This five-day workshop aims to establish an international consortium dedicated to addressing critical challenges in medicine through physics-based methodologies. The 2026 theme is:

Advancing Medicine Through Imaging for Cancer Treatment

Medical imaging provides critical insights for personalizing cancer treatment. By extracting quantitative parameters from images, we can:
- Automate cancer detection and treatment planning
- Establish international benchmarks to improve care quality
- Understand tumor dynamics and adapt treatments over time
 

The ultimate goal is to create a global consortium that advances cancer care through imaging biomarkers, characterizing tumor evolution, treatment interactions, and enabling automation in detection and therapy.
 

Participants have to submit a proposal using the template provided in the webpage. Projects may focus on:
- Research: Addressing a scientific question
- Open-Source Development: Creating tools (software, phantoms, methodologies) for shared use

Topics:
Imaging Biomarkers for Prediction and Response
- Modeling tumor evolution and therapy response (assessment of treatment response)
- Modeling emergence of treatment toxicity (assessment of treatment toxicity)
- Linking imaging biomarkers of response and toxicity to clinical outcomes (biomarkers as surrogate endpoints)

Standardization and Multimodal Integration
- Technical requirements for cross-center standardization of imaging biomarkers
- Integration of imaging biomarkers with non-imaging biomarkers (e.g., liquid biopsies, genomic and proteomic data)

Personalized and Adaptive Cancer Therapy
- Using quantitative imaging biomarkers to personalize therapy (radiotherapy, chemotherapy, immunotherapy)
- Dynamic adaptation of treatment strategies based on imaging biomarkers.